West Virginia Intellectual Property Cases

Cases filed
Cases 1 - 10 of 269
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00089
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00085
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff: Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2022cv00061
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al We have downloadable decisions or orders for this case
as 1:2022cv00035
Plaintiff: AstraZeneca AB and Astrazeneca Pharmaceuticals LP
Defendant: Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00032
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Smith v. US Federal Government Agencies et al
as 5:2022cv00154
Plaintiff: Margaret Jean Smith
Defendant: US Federal Government Agencies, Samsung Corp., Overseas, Corp. and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Trademark
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00023
Counter Defendant: Novo Nordisk, Inc. and Novo Nordisk, A/S
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al We have downloadable decisions or orders for this case
as 1:2022cv00020
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc
Defendant: Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?